Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
AMGN compared with CRDF: revenue, margins and what each company keeps, and the suppliers and customers both name
AMGN
Amgen Inc
Change
Mkt cap
Revenue
Revenue
CRDF
Cardiff Oncology, Inc.
Change
Mkt cap
Revenue
Revenue
vs
Compare
AMGN
Amgen Inc
vs
CRDF
Cardiff Oncology, Inc.
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Revenue flow
Desk
News
Calendar
Saved
Search
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Price
rebased to 0%
1D
1W
1M
3M
YTD
1Y
5Y
1D
1W
1M
3M
YTD
1Y
5Y
AMGN, solid
CRDF, dashed
Supply-chain overlap
Revenue flow
CRDF: latest quarter is a loss; flow not drawable.
Method
›
Supply-chain overlap
direct ties · both sides
Sources
›
direct ties · both sides
Only AMGN
12
PODD
Insulet
supplier
CYTK
Cytokinetics
supplier
ARWR
Arrowhead Pharmaceuticals
supplier
LGND
Ligand Pharmaceuticals
supplier
8 more · AMGN chain
›
Shared
0
No shared counterparties.
Only CRDF
3
PFE
Pfizer Ignite
supplier
—
Nerviano Medical Sciences
unlisted
supplier
—
MIT
unlisted
supplier
Role chip = supplier or customer
—
= no ticker (unlisted)
Source: SEC EDGAR
AMGN
Amgen Inc
Change
461.09
▲
+0.18%
Mkt cap
$249.0B
Revenue
$10.4B
Q3 FY26
Revenue
$36.8B
FY25
CRDF
Cardiff Oncology, Inc.
Change
0.79
▲
+3.97%
Regular session
Nov 6 '26
Mkt cap
$58.8M
Revenue
$104,000
Q2 FY26
Revenue
$593,000
FY25
vs
Compare
Regular session
Nov 6 '26
AMGN
Amgen Inc
vs
CRDF
Cardiff Oncology, Inc.
461.09
▲
+0.18%
Price
0.79
▲
+3.97%
$249.0B
Mkt cap
$58.8M
Q3 FY26
$10.4B
Revenue
$104,000
Q2 FY26
FY25
$36.8B
Revenue
$593,000
FY25
Change
Change
AMGN
461.09
▲
+0.18%
vs
CRDF
0.79
▲
+3.97%
Regular session
Nov 6 '26